Overview
Updated 14 Jul 2026
Michael Pishvaian, MD, is Associate Professor of Oncology at Johns Hopkins University / Johns Hopkins Kimmel Cancer Center (Sibley Memorial Hospital, Washington DC National Capital Region). The public record shows 544 publications with 9,809 citations (h-index 49), centered on Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 23 companies, 1 NIH-funded awards (2019–2022).
- Most recent indexed publication: 2026 · Nature communications
- Top research focus: Pancreatic and Hepatic Oncology Research
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 131.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- The Canopy Cancer Collective Clinical Registry Protocol
Sponsor: Canopy Cancer Collective, LLC
InvestigatorNot, yet, recruitingNCT07605702 - APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2RecruitingNCT04858334 - Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 1/PHASE2RecruitingNCT04172532
Industry payments
Updated 14 Jul 2026
23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novocure Inc.Program year202523 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Partner Therapeutics, Inc.Program year20255 payments
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2019–2022 per NIH RePORTER. The latest:
Congress activity
Updated 14 Jul 2026
165 congress contributions (2006–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Effect of surgeon specialty and health system characteristics on outcomes after pancreatic adenocarcinoma resection.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer.
JCO precision oncology
2025
Most-cited worksby citation count (OpenAlex)
- 01
- 03
- 04
- 05Sorafenib for Advanced and Refractory Desmoid Tumors453 citations2018
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
5255 Loughboro Road NW, Building B, Washington, DC 20016
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Editorial & leadership rolesjournal and society appointments
- Vice Chair
Scientific and Medical Advisory Board, Pancreatic Cancer Action Network (PanCAN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pancan.org ↗ - Alliance Co-Chair
Pancreatic Cancer Subcommittee; Alliance member, NIH Pancreatic Cancer Task Force
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aacr.org ↗
Secondary affiliationsappointments beyond the home institution
- Prior role: Co-Director for Clinical Research
Zayed Center for Pancreatic Cancer Research, MD Anderson Cancer Center
2019provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinsmedicine.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aacr.org ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncologytoday.captivate.fm ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- The Pancreatic Cancer Podcast
guest, precision medicine discussion with Drs. Winter and Brody
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Other
profiles.hopkinsmedicine.org/provider/mike-j-pishvaian/2705697
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Other
pure.johnshopkins.edu/en/persons/mike-pishvaian
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.johnshopkins.edu ↗ - ResearchGate
researchgate.net/scientific-contributions/Michael-J-Pishvaian-56095935
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- X / Twitter
x.com/tumorboardtues
- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - Doximity
Doximity profile: Dr. Michael Pishvaian, MD, Oncology, Washington, DC
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harry Quigley, MD
Johns Hopkins University
- 623
- publications
- 106
- h-index
- 4
- trials
Constantine Lyketsos, MD
Johns Hopkins University
- 763
- publications
- 105
- h-index
- 5
- trials
Robert Wise, MD
Johns Hopkins University
- 1,364
- publications
- 124
- h-index
- 11
- trials
Michael Carducci, MD
Johns Hopkins University
- 1,096
- publications
- 104
- h-index
- 20
- trials